CCM
GILD icon

Cribstone Capital Management’s Gilead Sciences GILD Stock Holding History

Cribstone Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$241K Hold
2,810
– – 0.14% 101
2022
Q3 		$173K Hold
2,810
– – 0.11% 113
2022
Q2 		$174K Hold
2,810
– – 0.11% 107
2022
Q1 		$167K Hold
2,810
– – 0.09% 113
2021
Q4 		$204K Hold
2,810
– – 0.11% 105
2021
Q3 		$196K Sell
2,810
-21
-0.7% -$1.48K 0.12% 106
2021
Q2 		$195K Hold
2,831
– – 0.12% 109
2021
Q1 		$183K Hold
2,831
– – 0.12% 109
2020
Q4 		$165K Buy
2,831
+2,630
+1,308% +$159K 0.11% 108
2020
Q3 		$13K Sell
201
-28
-12% -$1.94K 0.01% 184
2020
Q2 		$18K Hold
229
– – 0.01% 173
2020
Q1 		$17K Buy
229
+10
+5% +$691 0.02% 171
2019
Q4 		$14K Sell
219
-716
-77% -$46.6K 0.01% 237
2019
Q3 		$59K Sell
935
-215
-19% -$14.1K 0.04% 209
2019
Q2 		$78K Sell
1,150
-83
-7% -$5.46K 0.04% 198
2019
Q1 		$80K Sell
1,233
-761
-38% -$50.6K 0.04% 184
2018
Q4 		$125K Sell
1,994
-151
-7% -$10.6K 0.06% 149
2018
Q3 		$166K Sell
2,145
-462
-18% -$34.9K 0.08% 134
2018
Q2 		$185K Buy
2,607
+491
+23% +$34.7K 0.09% 125
2018
Q1 		$160K Buy
2,116
+268
+15% +$21.3K 0.08% 132
2017
Q4 		$132K Sell
1,848
-89
-5% -$6.76K 0.06% 179
2017
Q3 		$157K Sell
1,937
-72
-4% -$5.51K 0.08% 130
2017
Q2 		$142K Sell
2,009
-15,302
-88% -$1.02M 0.08% 142
2017
Q1 		$1.15M Sell
17,311
-1,480
-8% -$104K 0.63% 54
2016
Q4 		$1.33M Buy
18,791
+507
+3% +$37.7K 0.82% 36
2016
Q3 		$1.34M Buy
18,284
+354
+2% +$28.8K 0.82% 34
2016
Q2 		$1.5M Buy
17,930
+723
+4% +$64.2K 0.92% 29
2016
Q1 		$1.58M Buy
17,207
+1,858
+12% +$168K 1.27% 25
2015
Q4 		$1.57M Buy
+15,349
New +$1.6M 1.29% 23

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cribstone Capital Management's GILD Position: Q4 2022 in Review

Cribstone Capital Management held its Gilead Sciences (GILD) position steady in Q4 2022 at 2,810 shares worth $241K. The position accounts for 0.14% of the portfolio, ranked #101.

Cribstone Capital Management first reported a position in GILD in Q4 2015 and has held it in 29 quarters since. The position peaked at $1.58M in Q1 2016. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Cribstone Capital Management held 2,810 shares of Gilead Sciences worth $241K as of Q4 2022.
  • Cribstone Capital Management left its Gilead Sciences share count unchanged in Q4 2022.
  • Gilead Sciences made up 0.14% of Cribstone Capital Management's portfolio in Q4 2022, its #101 holding.
  • Cribstone Capital Management first reported a position in Gilead Sciences in Q4 2015 and has held it in 29 quarters since.
  • Cribstone Capital Management's Gilead Sciences position peaked at $1.58M in Q1 2016.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.